|
SKYE Skye Bioscience Inc 1516551 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-12,509,361.00 |
| Balance Sheet |
|
Current Assets
|
$18,566,969.00 |
|
Assets
|
$19,416,736.00 |
|
Current Liabilities
|
$10,404,932.00 |
|
Liabilities
|
$10,404,932.00 |
|
Equity
|
$9,011,804.00 |
|
Shares Out
|
35126884.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-8,557,917.00 |
|
Investing Cash Flow
|
$10,895,959.00 |
| Market Analysis |
Market Cap
|
$20,373,592.72 |
|
Price
|
$0.55 |
|
BVPS
|
0.26 |
|
PB
|
2.23 |
|
EPS
|
-0.32 |
|
FCF
|
$-8,557,917.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:42 |
|
| Apr |
May |
Jun |
| 2026-03-10 |
-0.36 |
|
|
2026-05-11 |
-0.32 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.44 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.32 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SKYE documents filed with the SEC.
SKYE Filings
Clear
